Evidence map›Paper›PMID 23641070›Full record

ArticleJournal of cell science2013

Evidence of a triosephosphate isomerase non-catalytic function crucial to behavior and longevity.

Bartholomew P Roland, Kimberly A Stuchul, Samantha B Larsen, Christopher G Amrich, Andrew P Vandemark, Alicia M Celotto, Michael J Palladino

Open access · greenAbstract read
In one paragraph

Article in Journal of cell science, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 37 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Comparative Transcriptome Analysis ofFrontiers in immunology · 2020
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Bartholomew P RolandDepartment of Pharmacology and Chemical Biology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261, USA.
Kimberly A Stuchul
Samantha B Larsen
Christopher G Amrich
Andrew P Vandemark
Alicia M Celotto
Michael J Palladino
University of Pittsburgh · USInstitute for Neurodegenerative Disorders · US

Funding

PREDOCTORAL TRAINING IN PHARMACOLOGICAL SCIENCEST32GM008424 · NIGMS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI PAGANO, PATRICK J · 1994 to 2019
$3.4M
Understanding the Mechanisms of NeuropathogenesisR01AG025046 · NIA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI PALLADINO, MICHAEL JOHN · 2006 to 2010
$1.5M
The Structural Basis of Shroom-Mediated Cell ContractilityR01GM097204 · NIGMS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI VANDEMARK, ANDREW PAUL · 2011 to 2015
$1.4M
Protein quality control mechanisms of novel soluble substratesR01GM103369 · NIGMS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI PALLADINO, MICHAEL JOHN · 2012 to 2015
$1.2M
Mitochondrial Dysfunction and Progressive EncephalomyopathiesR01AG027453 · NIA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI PALLADINO, MICHAEL JOHN · 2009 to 2010
$758k
NIA NIH HHS R01 AG025046NIA NIH HHS R01AG025046NIA NIH HHS R01 AG027453NIA NIH HHS R01AG027453NIGMS NIH HHS R01 GM097204NIGMS NIH HHS R01GM097204NIGMS NIH HHS R01 GM103369NIGMS NIH HHS R01GM103369NIGMS NIH HHS T32 GM008424NIGMS NIH HHS T32GM8424-17
6 · The paper itself

Abstract

Triosephosphate isomerase (TPI) is a glycolytic enzyme that converts dihydroxyacetone phosphate (DHAP) into glyceraldehyde 3-phosphate (GAP). Glycolytic enzyme dysfunction leads to metabolic diseases collectively known as glycolytic enzymopathies. Of these enzymopathies, TPI deficiency is unique in the severity of neurological symptoms. The Drosophila sugarkill mutant closely models TPI deficiency and encodes a protein prematurely degraded by the proteasome. This led us to question whether enzyme catalytic activity was crucial to the pathogenesis of TPI sugarkill neurological phenotypes. To study TPI deficiency in vivo we developed a genomic engineering system for the TPI locus that enables the efficient generation of novel TPI genetic variants. Using this system we demonstrate that TPI sugarkill can be genetically complemented by TPI encoding a catalytically inactive enzyme. Furthermore, our results demonstrate a non-metabolic function for TPI, the loss of which contributes significantly to the neurological dysfunction in this animal model.

Indexed as

LongevityAnemia, Hemolytic, Congenital NonspherocyticAnimalsCarbohydrate Metabolism, Inborn ErrorsCatalysisDihydroxyacetone PhosphateDisease Models, AnimalDrosophila melanogasterFemaleGene Knockout TechniquesGenetic Complementation TestGenetic EngineeringGlyceraldehyde 3-PhosphateGlycolysisHot TemperatureMaleDihydroxyacetone PhosphateGlyceraldehyde 3-PhosphateTriose-Phosphate IsomeraseDrosophila melanogasterGlycolysisLocomotor functionLongevityTPITriosephosphate isomerase

Identifiers

PMID23641070
PMCPMC3711204
OpenAlexW2145005202

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.